Ventas, Inc. (VTR) Stock Price: $84.60+0.71 (+0.85%)
At close: Jun 12, 2026, 4:00 PM ET
The closing share price for Ventas, Inc. (VTR) stock was $84.60 for Friday, June 12, 2026, up 0.85% on the day.
Longer view (total return, dividends reinvested): past 12 months +36.4% · 3-year avg +26.5%/yr · 5-year avg +11.5%/yr
VTR Price Chart
VTR Key Metrics
See All MetricsVTR Earnings Preview
Next Earnings Date
Jul 29, 2026
47 days away
EPS Estimate
0.14
Revenue Est.
$1.67B
Last Quarter Results
EPS
$0.10
vs Estimate
$0.10
Revenue
$1.66B
vs Estimate
$1.59B
VTR Analyst Ratings
Consensus Rating
Based on 20 analysts
Average Price Target
$96.80
+14.4% upside
Low
$86.00
Current
$84.60
High
$110.00
VTR Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $0.19 | $0.19 | $0.19 | 1 |
| Q2 2027 | $0.26 | $0.26 | $0.27 | 1 |
| Q3 2027 | $0.28 | $0.28 | $0.28 | 1 |
| Q4 2027 | $0.29 | $0.29 | $0.30 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.61 | $0.62 | $0.63 | 5 |
| FY 2027 | $0.99 | $1.02 | $1.08 | 6 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $1.76B | $1.78B | $1.81B | 1 |
| Q2 2027 | $1.78B | $1.80B | $1.82B | 2 |
| Q3 2027 | $1.82B | $1.84B | $1.86B | 2 |
| Q4 2027 | $1.84B | $1.86B | $1.88B | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $6.60B | $6.78B | $6.96B | 4 |
| FY 2027 | $7.13B | $7.39B | $7.74B | 4 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
VTR Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1VTR | $41.13B | $84.60 | +0.85% | +36.42% | +11.51% | +6.45% |
VTR Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Ventas, Inc.
As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- CEO
- Debra A. Cafaro